Brief: Vincerx Pharma Regains Compliance With Nasdaq Listing Rule 5550(A)(2)
16/01/2024 11:36
Jan 16 (Reuters) - Vincerx Pharma Inc VINC.O :
* VINCERX PHARMA- ON JANUARY 12, RECEIVED WRITTEN NOTICE
FROM
NASDAQ INFORMING CO IT HAS REGAINED COMPLIANCE WITH NASDAQ
LISTING RULE 5550(A)(2)
Further company coverage: VINC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign